Vascular Biology: Severing umbilical ties
Omphaloskepsis, or navel gazing, is a metaphor for contemplating life. Yet, how many of us ever consider the origins of this scar that is universal not only to human beings but to all placental mammals?
The belly button is a remnant of the umbilical cord that served as the baby’s anchor to life during pregnancy by creating a vascular bridge between fetal and maternal circulations. In humans, it is made up of one large vein that carries oxygen-filled blood to the baby, and two arteries that return the oxygen-depleted blood, as well as waste products, to the placenta (Figure 1A). This is the opposite of what happens in the adult body, where arteries carry blood rich in oxygen, and veins return blood depleted of oxygen to the heart, and is due to the dependence of the fetus on the placenta. This reversed scenario is the result of fetal vascular shunts, which provide an alternative path for blood flow at strategic points within the fetus.

The morphology of the umbilical arteries before and after birth.
(A) Umbilical arteries (dark blue) transport oxygen and nutrient-depleted blood to the placenta, while the umbilical vein (dark red) carries oxygen and nutrients to the fetus. During pregnancy, the umbilical arteries (cross-section, left side) have a thickened middle layer (the tunica media), whose outer layer is populated with contractile smooth muscle cells (SMCs; orange) and whose inner layer contains a high levels of proteins known as proteoglycans (light blue). (B) At birth, the umbilical arteries close rapidly (indicated by the yellow x) to prevent blood loss in the newborn. This is caused by the high local concentrations of proteoglycans, which enable the inner layer of the tunica media to swell and help the smooth muscle cells to contract more strongly (cross section, right side).
Created with BioRender.com.
Once the baby is born and takes its first breath, a change in oxygen levels in the umbilical arteries prompts the umbilical blood vessels to cease their rhythmic pulsing and the arteries to shut off, a process known as rapid umbilical artery closure (Figure 1B). This is followed by closure of the fetal shunts, thereby establishing the adult circulation. The umbilical vein, on the other hand, remains open for longer. Rapid umbilical artery closure prevents blood loss in the newborn as it detaches from its placenta, and is thought to occur naturally in all placental mammals. However, the mechanism is unclear.
Now, in eLife, Suneel Apte (Cleveland Clinic Lerner Research Institute), Jay Humphrey (Yale University) and colleagues – including Sumeda Nandadasa as first author – report new insights into how the anatomy and physiology of the umbilical vessels facilitate rapid umbilical closure (Nandadasa et al., 2020). The researchers – who are based at institutes in the US, UK and Sweden – used a multi-disciplinary approach to examine the morphological and molecular properties of umbilical blood vessels.
Nandadasa et al. first studied the morphology of the umbilical vessels in humans and mice, and then validated their findings across other placental mammals. In all species, the artery had a thicker middle layer (known as the tunica media) than the vein, and exhibited clear distinctions: the outer layer contained a higher number of smooth muscle cells; and the inner layer contained high levels of two proteins – aggrecan and versican – and low levels of ADAMTS1, an enzyme that cleaves these proteins. Moreover, the lumen of the artery was highly ruffled and partially occluded (Figure 1B). In the vein, the reverse was true: levels of ADAMTS1 were high, and levels of aggrecan and versican were low, and the lumen was much larger.
Aggregan and versican are both proteoglycans located outside of cells that help control the water content in the extracellular environment and provide compressive stiffness to tissues. Aggregan also plays a significant role in the biomechanics of cartilage, but its function in vascular biomechanics has been unclear. However, recent evidence suggests that too much aggregan may contribute to the progression of aneurysms, atherosclerosis and other vascular diseases (Koch et al., 2020). Based on the morphological and molecular properties of the umbilical artery, Nandadasa et al. postulated that prior to rapid umbilical artery closure, high local concentrations of proteoglycans cause the inner layer of the umbilical artery to swell, keeping it open during gestation. Then, at birth, the outer layers of smooth muscle cells contract, causing buckling of the underlying proteoglycan-rich layer and closure of the lumen.
Testing this hypothesis in the mouse model revealed that the smooth muscle cells in the outer wall of the artery were more contractile than those in the vein. Biomechanical tests confirmed that this was caused by the differentiation of the smooth muscle cells (to become more contractile) and by the high levels of proteoglycans, which decreased the distensibility of the arteries. A computational model was used to compare the relative contributions of the morphology of the tunica media, the contractions of smooth muscle cells, and the differential swelling of the umbilical artery, confirming that all three must be present for the artery to close.
Experiments on mice genetically engineered to be deficient in aggrecan and ADAMTS1 revealed that both proteins were needed for the growth of a normal umbilical cord. The results further confirmed that high levels of aggrecan were present when ADAMTS1 was absent, and vice versa. In both cases, the fetuses survived in the womb but died during birth. It could be possible that aggrecan and ADAMTS1 play a role in stillborn births, which are often linked to problems with the placenta and the umbilical cord (Stillbirth Collaborative Research Network Writing Group, 2011).
Mice that lacked ADAMTS1 also suffered from heart problems, furthering the evidence that many cardiovascular defects might be associated with abnormalities of the umbilical vasculature (Kwee et al., 1995; Yang et al., 1995; Oller et al., 2017). Rather than discarding the cord at birth, it may make sense to use it as a sentinel tissue for identifying potential cardiovascular risks later in life.
In summary, the work of Nandadasa et al. highlights the interactions between proteoglycans and smooth muscle cell differentiation, and the resulting biomechanics that facilitate rapid umbilical artery closure. It would be interesting to see if these principles also extend to the fetal shunts (e.g., Hung et al., 2018), or if they could be manipulated to treat diseases affected by blocked arteries. Moreover, they could be used to engineer vessels with a specific composition of proteoglycans to drive the desired differentiation of smooth muscle cells.
References
-
Molecular mechanisms for regulating postnatal ductus arteriosus closureInternational Journal of Molecular Sciences 19:1861–1874.https://doi.org/10.3390/ijms19071861
-
Aggrecan in cardiovascular development and diseaseJournal of Histochemistry & Cytochemistry 249:002215542095290.https://doi.org/10.1369/0022155420952902
-
Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient miceDevelopment 121:489–503.
-
Cell adhesion events mediated by alpha 4 integrins are essential in placental and cardiac developmentDevelopment 121:549–560.
Article and author information
Author details
Publication history
Copyright
© 2020, Wagenseil and Downs
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,615
- views
-
- 53
- downloads
-
- 2
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Computational and Systems Biology
In eukaryotes, protein kinase signaling is regulated by a diverse array of post-translational modifications, including phosphorylation of Ser/Thr residues and oxidation of cysteine (Cys) residues. While regulation by activation segment phosphorylation of Ser/Thr residues is well understood, relatively little is known about how oxidation of cysteine residues modulate catalysis. In this study, we investigate redox regulation of the AMPK-related brain-selective kinases (BRSK) 1 and 2, and detail how broad catalytic activity is directly regulated through reversible oxidation and reduction of evolutionarily conserved Cys residues within the catalytic domain. We show that redox-dependent control of BRSKs is a dynamic and multilayered process involving oxidative modifications of several Cys residues, including the formation of intramolecular disulfide bonds involving a pair of Cys residues near the catalytic HRD motif and a highly conserved T-loop Cys with a BRSK-specific Cys within an unusual CPE motif at the end of the activation segment. Consistently, mutation of the CPE-Cys increases catalytic activity in vitro and drives phosphorylation of the BRSK substrate Tau in cells. Molecular modeling and molecular dynamics simulations indicate that oxidation of the CPE-Cys destabilizes a conserved salt bridge network critical for allosteric activation. The occurrence of spatially proximal Cys amino acids in diverse Ser/Thr protein kinase families suggests that disulfide-mediated control of catalytic activity may be a prevalent mechanism for regulation within the broader AMPK family.
-
- Computational and Systems Biology
- Genetics and Genomics
Obesity is a major risk factor for type 2 diabetes, dyslipidemia, cardiovascular disease, and hypertension. Intriguingly, there is a subset of metabolically healthy obese (MHO) individuals who are seemingly able to maintain a healthy metabolic profile free of metabolic syndrome. The molecular underpinnings of MHO, however, are not well understood. Here, we report that CTRP10/C1QL2-deficient mice represent a unique female model of MHO. CTRP10 modulates weight gain in a striking and sexually dimorphic manner. Female, but not male, mice lacking CTRP10 develop obesity with age on a low-fat diet while maintaining an otherwise healthy metabolic profile. When fed an obesogenic diet, female Ctrp10 knockout (KO) mice show rapid weight gain. Despite pronounced obesity, Ctrp10 KO female mice do not develop steatosis, dyslipidemia, glucose intolerance, insulin resistance, oxidative stress, or low-grade inflammation. Obesity is largely uncoupled from metabolic dysregulation in female KO mice. Multi-tissue transcriptomic analyses highlighted gene expression changes and pathways associated with insulin-sensitive obesity. Transcriptional correlation of the differentially expressed gene (DEG) orthologs in humans also shows sex differences in gene connectivity within and across metabolic tissues, underscoring the conserved sex-dependent function of CTRP10. Collectively, our findings suggest that CTRP10 negatively regulates body weight in females, and that loss of CTRP10 results in benign obesity with largely preserved insulin sensitivity and metabolic health. This female MHO mouse model is valuable for understanding sex-biased mechanisms that uncouple obesity from metabolic dysfunction.